ProPhase Labs, Inc.
Pharmaceutical company · New York, United States · OTC: PRPH
ProPhase Labs, Inc. is a pharmaceutical company headquartered in New York, United States. Its shares trade on OTC under the ticker PRPH. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2025.
ProPhase Labs at a glance
What does ProPhase Labs do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $3 million sold (2025).
Frequently asked questions about ProPhase Labs
Where is ProPhase Labs headquartered?
ProPhase Labs, Inc. is headquartered in New York, United States.
What does ProPhase Labs do?
ProPhase Labs, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is ProPhase Labs a public company?
Yes. ProPhase Labs, Inc. trades on OTC under the ticker PRPH.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences